|
1
|
Allamand V, Broux O, Richard I,
Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C,
Pasturaud P, Pereira de Souza A, et al: Preferential localization
of the limb-girdle muscular dystrophy type 2A gene in the proximal
part of a 1-cM 15q15.1-q15.3 interval. Am J Hum Genet.
56:1417–1430. 1995.PubMed/NCBI
|
|
2
|
Bushby KM: Diagnostic criteria for the
limb-girdle muscular dystrophies: Report of the ENMC consortium on
limb-girdle dystrophies. Neuromuscul Disord. 5:71–74.
1995.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang CH, Liang WC, Minami N, Nishino I and
Jong YJ: Limb-girdle muscular dystrophy type 2A with mutation in
CAPN3: The first report in Taiwan. Pediatr Neonatol. 56:62–65.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zheng J, Xu X, Zhang X, Wang X, Shu J and
Cai C: Variants of CAPN3 cause limb-girdle muscular dystrophy type
2A in two Chinese families. Exp Ther Med. 21(104)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Richard I, Broux O, Allamand V,
Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C,
Pasturaud P, Roudaut C, et al: Mutations in the proteolytic enzyme
calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell.
81:27–40. 1995.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Feng X, Luo S, Li J, Yue D, Xi J, Zhu W,
Gao X, Guan X, Lu J, Liang Z and Zhao C: Fatty infiltration
evaluation and selective pattern characterization of lower limbs in
limb-girdle muscular dystrophy type 2A by muscle magnetic resonance
imaging. Muscle Nerve. 58:536–541. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mercuri E, Bushby K, Ricci E, Birchall D,
Pane M, Kinali M, Allsop J, Nigro V, Sáenz A, Nascimbeni A, et al:
Muscle MRI findings in patients with limb girdle muscular dystrophy
with calpain 3 deficiency (LGMD2A) and early contractures.
Neuromuscul Disord. 15:164–171. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Richard I, Brenguier L, Dinçer P, Roudaut
C, Bady B, Burgunder JM, Chemaly R, Garcia CA, Halaby G, Jackson
CE, et al: Multiple independent molecular etiology for limb-girdle
muscular dystrophy type 2A patients from various geographical
origins. Am J Hum Genet. 60:1128–1138. 1997.PubMed/NCBI
|
|
9
|
Groen EJ, Charlton R, Barresi R, Anderson
LV, Eagle M, Hudson J, Koref MS, Straub V and Bushby KM: Analysis
of the UK diagnostic strategy for limb girdle muscular dystrophy
2A. Brain. 130:3237–3249. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Vissing J, Barresi R, Witting N, Van
Ghelue M, Gammelgaard L, Bindoff LA, Straub V, Lochmüller H, Hudson
J, Wahl CM, et al: A heterozygous 21-bp deletion in CAPN3 causes
dominantly inherited limb girdle muscular dystrophy. Brain.
139:2154–2163. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Richard I, Roudaut C, Saenz A, Pogue R,
Grimbergen JE, Anderson LV, Beley C, Cobo AM, de Diego C, Eymard B,
et al: Calpainopathy-a survey of mutations and polymorphisms. Am J
Hum Genet. 64:1524–1540. 1999.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Kramerova I, Kudryashova E, Venkatraman G
and Spencer MJ: Calpain 3 participates in sarcomere remodeling by
acting upstream of the ubiquitin-proteasome pathway. Hum Mol Genet.
14:2125–2134. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ermolova N, Kudryashova E, DiFranco M,
Vergara J, Kramerova I and Spencer MJ: Pathogenity of some limb
girdle muscular dystrophy mutations can result from reduced
anchorage to myofibrils and altered stability of calpain 3. Hum Mol
Genet. 20:3331–3345. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Taveau M, Bourg N, Sillon G, Roudaut C,
Bartoli M and Richard I: Calpain 3 is activated through autolysis
within the active site and lyses sarcomeric and sarcolemmal
components. Mol Cell Biol. 23:9127–9135. 2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Martinez-Thompson JM, Niu Z, Tracy JA,
Moore SA, Swenson A, Wieben ED and Milone M: Autosomal dominant
calpainopathy due to heterozygous CAPN3 C.643_663del21. Muscle
Nerve. 57:679–683. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cerino M, Campana-Salort E, Salvi A,
Cintas P, Renard D, Morales RJ, Tard C, Leturcq F, Stojkovic T,
Bonello-Palot N, et al: Novel CAPN3 variant associated with an
autosomal dominant calpainopathy. Neuropathol Appl Neurobiol.
46:564–578. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
González-Mera L, Ravenscroft G,
Cabrera-Serrano M, Ermolova N, Domínguez-González C, Arteche-López
A, Soltanzadeh P, Evesson F, Navas C, Mavillard F, et al:
Heterozygous CAPN3 missense variants causing autosomal-dominant
calpainopathy in seven unrelated families. Neuropathol Appl
Neurobiol. 47:283–296. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sáenz A and López de Munain A: Dominant
LGMD2A: Alternative diagnosis or hidden digenism? Brain.
140(e7)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Vissing J and Duno M: Reply: Dominant
LGMD2A: Alternative diagnosis or hidden digenism? Brain.
140(e8)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cotta A, Carvalho E, da-Cunha-Júnior AL,
Valicek J, Navarro MM, Junior SB, da Silveira EB, Lima MI, Cordeiro
BA, Cauhi AF, et al: Muscle biopsy essential diagnostic advice for
pathologists. Surg Exp Pathol. 4(3)2021.
|
|
21
|
Wang C, Yue F and Kuang S: Muscle
histology characterization using H&E staining and muscle fiber
type classification using immunofluorescence staining. Bio Protoc.
7(e2279)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nix JS and Moore SA: What every
neuropathologist needs to know: The muscle biopsy. J Neuropathol
Exp Neurol. 79:719–733. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Suriyonplengsaeng C, Dejthevaporn C,
Khongkhatithum C, Sanpapant S, Tubthong N, Pinpradap K, Srinark N
and Waisayarat J: Immunohistochemistry of sarcolemmal
membrane-associated proteins in formalin-fixed and
paraffin-embedded skeletal muscle tissue: A promising tool for the
diagnostic evaluation of common muscular dystrophies. Diagn Pathol.
12(19)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Danielsson O and Häggqvist B: Skeletal
muscle immunohistochemistry of acquired and hereditary myopathies.
Curr Opin Rheumatol. 33:529–536. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang R, Chen S, Han P, Chen F, Kuang S,
Meng Z, Liu J, Sun R, Wang Z, He X, et al: Whole exome sequencing
identified a homozygous novel variant in CEP290 gene causes Meckel
syndrome. J Cell Mol Med. 24:1906–1916. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Van der Auwera GA, Carneiro M, Hartl C,
Poplin R, del Angel G, Levy-Moonshine A, Jordan T, Shakir K, Roazen
D, Thibault J, et al: From FastQ data to high confidence variant
calls: The genome analysis toolkit best practices pipeline. Curr
Protoc Bioinformatics: Mar 15, 2018 (Epub ahead of print). doi:
10.1002/0471250953.bi1110s43.
|
|
27
|
Gu S, Fang L and Xu X: Using SOAPaligner
for short reads alignment. Curr Protoc Bioinformatics.
44(11.11.1-17)2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li R, Yu C, Li Y, Lam TW, Yiu SM,
Kristiansen K and Wang J: SOAP2: An improved ultrafast tool for
short read alignment. Bioinformatics. 25:1966–1967. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sherry ST, Ward MH, Kholodov M, Baker J,
Phan L, Smigielski EM and Sirotkin K: dbSNP: The NCBI database of
genetic variation. Nucleic Acids Res. 29:308–311. 2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Clark AG, Hubisz MJ, Bustamante CD,
Williamson SH and Nielsen R: Ascertainment bias in studies of human
genome-wide polymorphism. Genome Res. 15:1496–1502. 2005.PubMed/NCBI View Article : Google Scholar
|
|
31
|
1000 Genomes Project Consortium. Auton A,
Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL,
McCarthy S, McVean GA and Abecasis GR: A global reference for human
genetic variation. Nature. 526:68–74. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Stenson PD, Ball EV, Mort M, Phillips AD,
Shiel JA, Thomas NST, Abeysinghe S, Krawczak M and Cooper DN: Human
gene mutation database (HGMD): 2003 Update. Hum Mutat. 21:577–581.
2003.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hamosh A, Scott AF, Amberger JS, Bocchini
CA and McKusick VA: Online mendelian inheritance in man (OMIM), a
knowledgebase of human genes and genetic disorders. Nucleic Acids
Res. 33:D514–D517. 2005.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Karczewski KJ, Weisburd B, Thomas B,
Solomonson M, Ruderfer DM, Kavanagh D, Hamamsy T, Lek M, Samocha
KE, Cummings BB, et al: The ExAC browser: Displaying reference data
information from over 60 000 exomes. Nucleic Acids Res. 45
(D1):D840–D845. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Karczewski KJ, Francioli LC, Tiao G,
Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A,
Birnbaum DP, et al: The mutational constraint spectrum quantified
from variation in 141,456 humans. Nature. 581:434–443.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lefter M, Vis JK, Vermaat M, den Dunnen
JT, Taschner PEM and Laros JFJ: Mutalyzer 2: Next generation HGVS
nomenclature checker. Bioinformatics. 37:2811–2817. 2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Vanhoutte EK, Faber CG, van Nes SI, Jacobs
BC, van Doorn PA, van Koningsveld R, Cornblath DR, van der Kooi AJ,
Cats EA, van den Berg LH, et al: Modifying the medical research
council grading system through Rasch analyses. Brain.
135:1639–1649. 2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chang RF and Mubarak SJ: Pathomechanics of
Gowers' sign: A video analysis of a spectrum of Gowers' maneuvers.
Clin Orthop Relat Res. 470:1987–1991. 2012.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Partha SK, Ravulapalli R, Allingham JS,
Campbell RL and Davies PL: Crystal structure of calpain-3
penta-EF-hand (PEF) domain-a homodimerized PEF family member with
calcium bound at the fifth EF-hand. FEBS J. 281:3138–3149.
2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Gallardo E, Saenz A and Illa I:
Limb-girdle muscular dystrophy 2A. Handb Clin Neurol. 101:97–110.
2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Huang Y, de Morrée A, van Remoortere A,
Bushby K, Frants RR, den Dunnen JT and van der Maarel SM: Calpain 3
is a modulator of the dysferlin protein complex in skeletal muscle.
Hum Mol Genet. 17:1855–1866. 2008.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Toral-Ojeda I, Aldanondo G,
Lasa-Elgarresta J, Lasa-Fernández H, Fernández-Torrón R, López de
Munain A and Vallejo-Illarramendi A: Calpain 3 deficiency affects
SERCA expression and function in the skeletal muscle. Expert Rev
Mol Med. 18(e7)2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Jahnke VE, Peterson JM, Van Der Meulen JH,
Boehler J, Uaesoontrachoon K, Johnston HK, Defour A, Phadke A, Yu
Q, Jaiswal JK and Nagaraju K: Mitochondrial dysfunction and
consequences in calpain-3-deficient muscle. Skelet Muscle.
10(37)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chen L, Tang F, Gao H, Zhang X, Li X and
Xiao D: CAPN3: A muscle-specific calpain with an important role in
the pathogenesis of diseases (review). Int J Mol Med.
48(203)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lasa-Elgarresta J, Mosqueira-Martín L,
González-Imaz K, Marco-Moreno P, Gerenu G, Mamchaoui K, Mouly V,
López de Munain A and Vallejo-Illarramendi A: Targeting the
ubiquitin-proteasome system in limb-girdle muscular dystrophy with
CAPN3 mutations. Front Cell Dev Biol. 10(822563)2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kramerova I, Torres JA, Eskin A, Nelson SF
and Spencer MJ: Calpain 3 and CaMKIIβ signaling are required to
induce HSP70 necessary for adaptive muscle growth after atrophy.
Hum Mol Genet. 27:1642–1653. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Lasa-Elgarresta J, Mosqueira-Martín L,
Naldaiz-Gastesi N, Sáenz A, López de Munain A and
Vallejo-Illarramendi A: Calcium mechanisms in limb-girdle muscular
dystrophy with CAPN3 mutations. Int J Mol Sci.
20(4548)2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Place N, Ivarsson N, Venckunas T, Neyroud
D, Brazaitis M, Cheng AJ, Ochala J, Kamandulis S, Girard S,
Volungevičius G, et al: Ryanodine receptor fragmentation and
sarcoplasmic reticulum Ca2+ leak after one session of
high-intensity interval exercise. Proc Natl Acad Sci USA.
112:15492–15497. 2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Mitsuhashi S and Kang PB: Update on the
genetics of limb girdle muscular dystrophy. Semin Pediatr Neurol.
19:211–218. 2012.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Guglieri M, Magri F, D'Angelo MG, Prelle
A, Morandi L, Rodolico C, Cagliani R, Mora M, Fortunato F, Bordoni
A, et al: Clinical, molecular, and protein correlations in a large
sample of genetically diagnosed Italian limb girdle muscular
dystrophy patients. Hum Mutat. 29:258–266. 2008.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Balci B, Aurino S, Haliloglu G, Talim B,
Erdem S, Akcören Z, Tan E, Caglar M, Richard I, Nigro V, et al:
Calpain-3 mutations in Turkey. Eur J Pediatr. 165:293–298.
2006.PubMed/NCBI View Article : Google Scholar
|
|
54
|
de Paula F, Vainzof M, Passos-Bueno MR, de
Cássia M, Pavanello R, Matioli SR, V B Anderson L, Nigro V and Zatz
M: Clinical variability in calpainopathy: What makes the
difference? Eur J Hum Genet. 10:825–832. 2002.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Fanin M, Nascimbeni AC, Fulizio L and
Angelini C: The frequency of limb girdle muscular dystrophy 2A in
northeastern Italy. Neuromuscul Disord. 15:218–224. 2005.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Fanin M, Nascimbeni AC, Tasca E and
Angelini C: How to tackle the diagnosis of limb-girdle muscular
dystrophy 2A. Eur J Hum Genet. 17:598–603. 2009.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Dorobek M, Ryniewicz B, Kabzińska D,
Fidziańska A, Styczyńska M and Hausmanowa-Petrusewicz I: The
Frequency of c.550delA mutation of the CANP3 gene in the Polish
LGMD2A population. Genet Test Mol Biomarkers. 19:637–640.
2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Piluso G, Politano L, Aurino S, Fanin M,
Ricci E, Ventriglia VM, Belsito A, Totaro A, Saccone V, Topaloglu
H, et al: Extensive scanning of the calpain-3 gene broadens the
spectrum of LGMD2A phenotypes. J Med Genet. 42:686–693.
2005.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Pogoda TV, Krakhmaleva IN, Lipatova NA,
Shakhovskaya NI, Shishkin SS and Limborska SA: High incidence of
550delA mutation of CAPN3 in LGMD2 patients from Russia. Hum Mutat.
15(295)2000.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Milic A and Canki-Klain N: Calpainopathy
(LGMD2A) in Croatia: Molecular and haplotype analysis. Croat Med J.
46:657–663. 2005.PubMed/NCBI
|
|
61
|
Duguez S, Bartoli M and Richard I: Calpain
3: A key regulator of the sarcomere? FEBS J. 273:3427–3436.
2006.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Foley AR, Donkervoort S and Bönnemann CG:
Next-generation sequencing still needs our generation's clinicians.
Neurol Genet. 1(e13)2015.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Şahin İO, Özkul Y and Dündar M: Current
and future therapeutic strategies for limb girdle muscular
dystrophy type R1: Clinical and experimental approaches.
Pathophysiology. 28:238–249. 2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Li C and Samulski RJ: Engineering
adeno-associated virus vectors for gene therapy. Nat Rev Genet.
21:255–272. 2020.PubMed/NCBI View Article : Google Scholar
|
